ADMA Biologics Reports Year End 2015 Financial Results, Accomplishments and Upcoming Milestones

Go back to ADMA Biologics Reports Year End 2015 Financial Results, Accomplishments and Upcoming Milestones

ADMA Biologics (ADMA) Reports Q4 Loss of $0.58

March 23, 2016 4:31 PM EDT

ADMA Biologics (NASDAQ: ADMA) reported Q4 EPS of ($0.58), versus $0.50 reported last year. Revenue for the quarter came in at $524 thousand, versus $30 million reported last year.

For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.

... More